Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8597 in de novo kidney transplant recipients
NCT01442337Phase 3Terminated
- Sponsor
- Astellas Pharma
- Start
- Dec 2011
- Primary completion
- Jul 2013
- Countries
- 1
01
Overview
A Phase 3 trial of Diannexin in kidney transplantation, sponsored by Astellas Pharma. Started Dec 2011; status: terminated.
02
Drugs
Diannexin
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01442337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442337.